Search results
Some carbs are good for you. The key is choosing the right ones.
Washington Post· 4 days agoConsumer Reports has no financial relationship with any advertisers on this site. “They also provide...
Study hints at tools to prevent diabetes associated with antipsychotic medications
Medical Xpress· 20 hours agoNew University of Pittsburgh research points to a potential approach to reducing the risk of...
Can a Compound Found in Red Wine Help Your Skin? The Truth About Resveratrol
Vogue· 22 hours agoIt’s not that I don’t want to look good, it’s just that lately, I’ve preferred to focus on longevity...
Arrokoth the 'space snowman' probably tastes like sweet soap
Space via Yahoo News· 6 days agoThe simulated radiation set off a series of chemical reactions in the ice, which led to the...
Common low-calorie sweetener linked to heart attack and stroke, study finds - WSVN 7News | Miami...
7 News Miami· 7 days agoStanley Hazen, director of the Center for Cardiovascular Diagnostics and Prevention at the Cleveland...
Scented Water Can Make Every Sip More Slimming: The Easy How-To
First for Women via Yahoo News· 3 days ago“Adding essential oils to a diffuser brings in aromatic plant molecules, an ingenious but often...
Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA's 84th Scientific...
Morningstar· 2 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology ...
The late, great Michael Mosley’s 11 tips to living well
The Telegraph via Yahoo News· 4 days agoMichael Mosley was known for his simple lifestyle tips – including the 5:2 diet – on how to live a...
Uncovering links between mental stress and physical health, including cardiovascular disease
Medical Xpress· 2 days agoTo explore the link between short-term, acute mental stress and physical effects, including heart...
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients...
StreetInsider· 5 days agoEli Lilly and Company (NYSE: LLY) announced detailed results from SYNERGY-NASH, a phase 2 study of 190 patients, with or without type 2 diabetes, to evaluate the investigational use of tirzepatide ...